Clinical trial
Brain Outcomes With Lifestyle Change in Down Syndrome
Recruiting now · Not applicable · 1 countries · Registry ID NCT05985486
What this study is about
The goal of this study is to determine if weight loss or changes in dietary intake can help prevent of delay adults with Down syndrome from developing Alzheimer's Disease Adults with Down syndrome without dementia will be randomized to either a weight loss group or a general health education control group. The weight loss group will be asked to follow a reduced energy diet, attend monthly education sessions delivered remotely and self-monitor diet and body weight using commercially available web-based applications. The control group will be asked to attend remotely delivered monthly education sessions on general health education topics. All participants will come to the University of Kansas Medical Center, 3 times across 12 months for a blood draw, cognitive testing, a MRI, assessment of height and weight, and assessment of diet intake.
Basic eligibility
Full registry criteria
Treatments and study arms
Diet
A reduced calorie diet which uses frozen meals purchased at the store and focuses on increasing fruits and vegetables associated with brain health.
Health Education
Monthly health education sessions delivered remotely.
Primary outcomes
Examines the amount of amyloid beta in a person's brain, measured by a blood draw.
Examines the amount of Neurofilament light in a person's brain, measured by a blood draw.
Examines how much a person weights, measured by standing on a scale.
Study locations
1 locations were listed when this page was built. The first 40 are shown.